Patient Copayments, Provider Incentives, and Income Effects: Theory and Evidence From the Essential Medications List Under China's 2009 Healthcare Reform
Authors:
- Brian K. ChenBCBrian K. Chen
- Y. Tony YangYYY. Tony Yang
- Karen EgglestonKEKaren Eggleston
Open Access
- 16 March 2017
- journal article
- research article
- Published by Wiley in World Medical & Health Policy
- Vol. 9 (1) , 24-44
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Addressing antibiotic abuse in China: An experimental audit studyJournal of Development Economics, 2014
- Patient Copayments, Provider Incentives and Income Effects: Theory and Evidence from China's Essential Medications List PolicySSRN Electronic Journal, 2013
- National Essential Medicines List and policy practice: A case study of China’s health care reformBMC Health Services Research, 2012
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered ApproachDiabetes Care, 2012
- Prescribing institutions: Explaining the evolution of physician dispensingJournal of Institutional Economics, 2011
- Prevalence of Diabetes among Men and Women in ChinaNew England Journal of Medicine, 2010
- Pharmaceutical Policy In ChinaHealth Affairs, 2008
- Multitasking and mixed systems for provider paymentJournal of Health Economics, 2005
- Supply-Side and Demand-Side Cost Sharing in Health CareJournal of Economic Perspectives, 1993
- Physician response to fee changes with multiple payersJournal of Health Economics, 1991